FranceFrance

Bio-people

26.11.2005

Neurotech S.A. (Paris, France) has named Ted Danse as new President and Chief Executive Officer. Danse has a record of more than 25 years in life science industries. He served as President and CEO of the public US ophthalmic pharmaceutical company ISTA Pharmaceuticals Inc. and was Director on the boards of Quest Vision Technologies, Inc. and Vision Solutions Technologies, Inc. Other stations of his carreer include business development roles at Coopervision, Bausch & Lomb, Schering-Plough and Allergan.

FranceFrance

08.01.2010

Leverkusen – German dermatology specialist Biofrontera AG’s experimental treatment for the skin disorder actinic keratosis has outperformed the current treatment standard, Metvix. According to the results of a multi-centre phase...

FranceFrance

26.11.2009

Nice – French NicOx SA has announced that it will be further increasing its capital with the aim of expanding the supply of its lead candidate Naproxcinod, and to implement a sales team in the US market, for which the company is...

BeNeLux, France, UK, PortugalFrance

02.11.2009

Lissabon/Leicester/Oeiras/Strasbourg/Utrecht - A set of genes that is known to control many aspects of embryonic development is also involved in determining the number of vertebrae in the spine, according to the results of new...

Germany, FranceFrance

31.10.2009

Bethesda/Munich/Paris - Micromet Inc. partnered with sanofi-aventis Group to develop one of the biotech's bispecific T cell engager (BiTE) antibodies for cancer. The Paris-based pharma will pay €8 million up front, and Micromet...

FranceFrance

28.10.2009

Paris - French President Nicolas Sarkozy at the fourth session of the Strategic Council for Health Industries has announced an investment of €139 million ($206.5 million ) for the establishment of a biotechnology fund. The...

Denmark, Germany, France, UKFrance

02.10.2009

Strasbourg – By studying mosquito genomes, researchers have identified differences in the expression of a single gene that determines whether or not a mosquito can transmit malaria parasites. This discovery provides a genetic...

FranceFrance

30.09.2009

Grenoble – French specialists in high content screening (HCS), Cytoo SA, have secured EUR3m in a second funding round led by its new investor Auriga Partners. The one year old company said it will use the money to expand its...

FranceFrance

20.09.2009

Paris – Nearly half of all French universities are aiming to raise private money by setting up new foundations. By January of 2010, more than 60 academic institutions will be declared autonomous and given the freedom to build...

FranceFrance

20.09.2009

Paris – Two US companies with French roots have listed on the Euronext without raising money. Cardiovascular, neurology and metabolic company Quantum Genomics Corp. registered 39.3 million shares for trading at EUR1.04. The...

Editorial, FranceFrance

20.09.2009

The present crisis marks a major breaking point in the growth model and the financial fundamentals upon which mature economies are based. It has raised important issues concerning value creation, innovation and – above all – the...

Displaying results 91 to 100 out of 268

< Previous 91-100 Next >

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/nc/news/messages-archive/archive-france/browse/9/article/bio-people-2.html

Events

All Events

Stock list

All quotes

TOP

  • NOVACYT (F)4.97 EUR11.43%
  • PROSENSA (NL)10.24 USD5.89%
  • NEUROVIVE PHARMACEUTICAL AB (S)74.00 SEK5.71%

FLOP

  • ANTISOMA (UK)1.32 GBP-14.84%
  • XENETIC BIOSCIENCES (UK)6.00 GBP-14.29%
  • STENTYS (F)7.26 EUR-12.32%

TOP

  • WILEX (D)2.70 EUR229.3%
  • NEUROVIVE PHARMACEUTICAL AB (S)74.00 SEK52.6%
  • Allergy Therapeutics (UK)20.00 GBP34.4%

FLOP

  • HYBRIGENICS (F)1.68 EUR-29.7%
  • GW PHARMACEUTICALS (UK)418.50 GBP-20.1%
  • PHARMING (NL)0.44 EUR-20.0%

TOP

  • SANTHERA (CH)59.90 CHF2836.3%
  • GW PHARMACEUTICALS (UK)418.50 GBP634.2%
  • PAION (D)2.50 EUR284.6%

FLOP

  • EVOCUTIS (UK)0.21 GBP-92.7%
  • CYTOS (CH)0.27 CHF-92.0%
  • THROMBOGENICS (B)9.16 EUR-70.3%

No liability assumed, Date: 31.07.2014


Current issue

All issues

Product of the week

Products